As a follow up to a previous report of DCA and Avemar working against AML Leukemia, a new case has surfaced of the protocol working against Chronic lymphocytic leukemia (CLL) Leukemia.

The term “chronic” in chronic lymphocytic leukemia comes from the fact that it typically progresses more slowly than other types of leukemia. The term “lymphocytic” in chronic lymphocytic leukemia comes from the cells affected by the disease — a group of white blood cells called lymphocytes, which help your body fight infection.

— http://www.mayoclinic.com/health/chronic-lymphocytic-leukemia/DS00565 

The patient initially responded favourably to DCA alone, but when Avemar was added, the response was dramatically better (measured by the cell counts).

— Dr. Akbar Khan, Medicor Cancer Centres

Here is a link to the case study involving AML Leukemia:

http://www.martincwiner.com/dca-and-avemar-show-clinical-promise-against-aml-leukemia/

And here is a link to the original video discussing the protocol:

http://www.martincwiner.com/dca-and-avemar-a-theoretical-protocol-for-cancer/